Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease.

Guy CD, Suzuki A, Burchette JL, Brunt EM, Abdelmalek MF, Cardona D, McCall SJ, Ünalp A, Belt P, Ferrell LD, Diehl AM; Nonalcoholic Steatohepatitis Clinical Research Network.

Hum Pathol. 2012 Jun;43(6):790-800. doi: 10.1016/j.humpath.2011.07.007. Epub 2011 Oct 28.

2.

Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis.

Lackner C, Gogg-Kamerer M, Zatloukal K, Stumptner C, Brunt EM, Denk H.

J Hepatol. 2008 May;48(5):821-8. doi: 10.1016/j.jhep.2008.01.026. Epub 2008 Feb 22.

PMID:
18329127
3.

Increased production of sonic hedgehog by ballooned hepatocytes.

Rangwala F, Guy CD, Lu J, Suzuki A, Burchette JL, Abdelmalek MF, Chen W, Diehl AM.

J Pathol. 2011 Jul;224(3):401-10. doi: 10.1002/path.2888. Epub 2011 May 5.

4.

Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning.

Fujii H, Ikura Y, Arimoto J, Sugioka K, Iezzoni JC, Park SH, Naruko T, Itabe H, Kawada N, Caldwell SH, Ueda M.

J Atheroscler Thromb. 2009;16(6):893-901. Epub 2009 Dec 22.

5.

The genetic background modulates susceptibility to mouse liver Mallory-Denk body formation and liver injury.

Hanada S, Strnad P, Brunt EM, Omary MB.

Hepatology. 2008 Sep;48(3):943-52. doi: 10.1002/hep.22436.

PMID:
18697208
6.

[Alcoholic and nonalcoholic steatohepatitis. Histopathologic and pathogenetic considerations].

Denk H, Stumptner C, Fuchsbichler A, Zatloukal K.

Pathologe. 2001 Nov;22(6):388-98. German.

PMID:
11766638
7.

Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients.

Valva P, De Matteo E, Galoppo M, Pedreira A, Giacove G, Lezama C, Marco I, Galoppo MC, Preciado MV.

Hum Pathol. 2008 Dec;39(12):1816-22. doi: 10.1016/j.humpath.2008.04.022. Epub 2008 Aug 20.

PMID:
18715620
8.

Mallory-Denk bodies: Correlation with steatosis, severity, zonal distribution, and identification with ubiquitin.

Kayaçetin S, Başaranoğlu M.

Turk J Gastroenterol. 2015 Nov;26(6):506-10. doi: 10.5152/tjg.2015.150199. Epub 2015 Oct 22.

9.

The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis.

Le TH, Caldwell SH, Redick JA, Sheppard BL, Davis CA, Arseneau KO, Iezzoni JC, Hespenheide EE, Al-Osaimi A, Peterson TC.

Hepatology. 2004 May;39(5):1423-9.

PMID:
15122772
10.

Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity.

Guy CD, Suzuki A, Abdelmalek MF, Burchette JL, Diehl AM; NASH CRN.

Hepatology. 2015 Jan;61(1):98-107. doi: 10.1002/hep.27235. Epub 2014 Aug 25.

11.

Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease.

Maliken BD, Nelson JE, Klintworth HM, Beauchamp M, Yeh MM, Kowdley KV.

Hepatology. 2013 May;57(5):1806-13. doi: 10.1002/hep.26238. Epub 2013 Mar 14.

12.

Acidophil bodies in nonalcoholic steatohepatitis.

Yeh MM, Belt P, Brunt EM, Kowdley KV, Wilson LA, Ferrell L; Nonalcoholic Steatohepatitis Clinical Research Network.

Hum Pathol. 2016 Jun;52:28-37. doi: 10.1016/j.humpath.2016.01.001. Epub 2016 Feb 1.

13.

Automatic quantification of lobular inflammation and hepatocyte ballooning in nonalcoholic fatty liver disease liver biopsies.

Vanderbeck S, Bockhorst J, Kleiner D, Komorowski R, Chalasani N, Gawrieh S.

Hum Pathol. 2015 May;46(5):767-75. doi: 10.1016/j.humpath.2015.01.019. Epub 2015 Feb 19.

14.

M-30 and 4HNE are sequestered in different aggresomes in the same hepatocytes.

Amidi F, French BA, Chung D, Halsted CH, Medici V, French SW.

Exp Mol Pathol. 2007 Dec;83(3):296-300. Epub 2007 Oct 25.

15.

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.

Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE.

Hepatology. 2006 Jul;44(1):27-33.

PMID:
16799979
16.

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease.

Kim YS, Jung ES, Hur W, Bae SH, Choi JY, Song MJ, Kim CW, Jo SH, Lee CD, Lee YS, Choi SW, Yang JM, Jang JW, Kim SG, Jung SW, Kim HK, Chae HB, Yoon SK.

Clin Mol Hepatol. 2013 Jun;19(2):120-30. doi: 10.3350/cmh.2013.19.2.120. Epub 2013 Jun 27.

17.

Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?

Machado MV, Cortez-Pinto H.

Expert Rev Gastroenterol Hepatol. 2011 Apr;5(2):213-22. doi: 10.1586/egh.11.16. Review.

PMID:
21476916
18.

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients.

Diab DL, Yerian L, Schauer P, Kashyap SR, Lopez R, Hazen SL, Feldstein AE.

Clin Gastroenterol Hepatol. 2008 Nov;6(11):1249-54. doi: 10.1016/j.cgh.2008.07.016. Epub 2008 Jul 26.

19.

Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.

Lackner C.

Expert Rev Gastroenterol Hepatol. 2011 Apr;5(2):223-31. doi: 10.1586/egh.11.8. Review.

PMID:
21476917
20.

Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease.

Sanchez-Pareja A, Clément S, Peyrou M, Spahr L, Negro F, Rubbia-Brandt L, Foti M.

World J Gastroenterol. 2016 Apr 14;22(14):3735-45. doi: 10.3748/wjg.v22.i14.3735.

Supplemental Content

Support Center